340 related articles for article (PubMed ID: 33450697)
1. Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene.
Qin Z; Sun L; Sun X; Gao X; Su H
Stem Cell Res; 2021 Mar; 51():102163. PubMed ID: 33450697
[TBL] [Abstract][Full Text] [Related]
2. A generated induced pluripotent stem cell (iPSC) line (CMGANTi005-A) of a Marfan syndrome patient with an FBN1 c.7754T > C (p.Ile2585Thr) variation.
Van Den Heuvel LJF; Peeters S; Meester JAN; Perik M; Coucke P; Loeys BL
Stem Cell Res; 2023 Mar; 67():103032. PubMed ID: 36708686
[TBL] [Abstract][Full Text] [Related]
3. Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p.Cys1791Tyr) variant.
Peeters S; Fedoryshchenko I; Rabaut L; Verstraeten A; Loeys BL
Stem Cell Res; 2023 Apr; 68():103050. PubMed ID: 36801568
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1.
Li X; Dong T; Li Y; Wu F; Lan F
Stem Cell Res; 2019 Apr; 36():101414. PubMed ID: 30870686
[TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation.
Pan Z; Wang H; Wang H; Liu Y; Liang P
Stem Cell Res; 2021 Aug; 55():102459. PubMed ID: 34298435
[TBL] [Abstract][Full Text] [Related]
6. Generation of Marfan patient specific iPSCs (ICSSUi001-A) carrying a novel heterozygous mutation in FBN1 gene.
Yu Y; Shen H; Zhu J; Cao X; Li Q; Shao L; Shen Z
Stem Cell Res; 2022 Apr; 60():102720. PubMed ID: 35231796
[TBL] [Abstract][Full Text] [Related]
7. A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G>A mutation, ISMMSi002-B, for disease modeling.
Klein S; Dvornik JL; Yarrabothula AR; Schaniel C
Stem Cell Res; 2017 Aug; 23():73-76. PubMed ID: 28925368
[TBL] [Abstract][Full Text] [Related]
8. Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del).
Ma B; Luo M; Yang H; Li T; Liu W; Xu F; Shu C; Chen G; Zhou Z
Stem Cell Res; 2020 Jan; 42():101690. PubMed ID: 31901832
[TBL] [Abstract][Full Text] [Related]
9. Generation of genetically modified human induced pluripotent stem cell lines harboring haploin sufficient or dominant negative variants in the FBN1 gene.
Borsoi J; Farinha-Arcieri LE; Morato-Marques M; Delgado Sarafian R; Pinheiro M; Veiga Pereira L
Stem Cell Res; 2021 Jul; 54():102434. PubMed ID: 34174776
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human iPSC line QDMHi001-A from a patient with Marfan syndrome carrying a heterozygous c.6772 T > C variant in FBN1.
Wu S; Zhang Z; Wang L; Yu J
Stem Cell Res; 2021 Jul; 54():102390. PubMed ID: 34087733
[TBL] [Abstract][Full Text] [Related]
11. Recapitulating and Correcting Marfan Syndrome in a Cellular Model.
Park JW; Yan L; Stoddard C; Wang X; Yue Z; Crandall L; Robinson T; Chang Y; Denton K; Li E; Jiang B; Zhang Z; Martins-Taylor K; Yee SP; Nie H; Gu F; Si W; Xie T; Yue L; Xu RH
Int J Biol Sci; 2017; 13(5):588-603. PubMed ID: 28539832
[TBL] [Abstract][Full Text] [Related]
12. Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing.
Aalders J; Léger L; Demolder A; Muiño Mosquera L; Coucke P; Menten B; De Backer J; van Hengel J
Stem Cell Res; 2023 Mar; 67():103036. PubMed ID: 36724552
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells.
Iosef C; Pedroza AJ; Cui JZ; Dalal AR; Arakawa M; Tashima Y; Koyano TK; Burdon G; Churovich SMP; Orrick JO; Pariani M; Fischbein MP
Sci Rep; 2020 Nov; 10(1):20392. PubMed ID: 33230159
[TBL] [Abstract][Full Text] [Related]
14. Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene.
Li T; Ma B; Yang H; Zhu G; Shu C; Luo M; Zhou Z
Stem Cell Res; 2021 Oct; 56():102543. PubMed ID: 34592602
[TBL] [Abstract][Full Text] [Related]
15. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells.
Quarto N; Li S; Renda A; Longaker MT
Stem Cells; 2012 Dec; 30(12):2709-19. PubMed ID: 23037987
[TBL] [Abstract][Full Text] [Related]
16. Generation of two human induced pluripotent stem cell (hiPSC) lines derived from unrelated Marfan Syndrome patients.
Borsoi J; Morato-Marques M; de Araújo Tofoli F; Assis Pereira L; Farinha-Arcieri LE; Delgado Sarafian R; Alvarez Perez AB; Veiga Pereira L
Stem Cell Res; 2021 Jul; 54():102407. PubMed ID: 34062330
[TBL] [Abstract][Full Text] [Related]
17. Mutation screening in the FBN1 gene responsible for Marfan syndrome and related disorder in Chinese families.
Gong B; Yang L; Wang Q; Ye Z; Guo X; Yang C; Hao F; Shi Y; Huang Y; Qu C; Yang Z
Mol Genet Genomic Med; 2019 Apr; 7(4):e00594. PubMed ID: 30838813
[TBL] [Abstract][Full Text] [Related]
18. A novel fibrillin-1 gene missense mutation associated with neonatal Marfan syndrome: a case report and review of the mutation spectrum.
Peng Q; Deng Y; Yang Y; Liu H
BMC Pediatr; 2016 Apr; 16():60. PubMed ID: 27138491
[TBL] [Abstract][Full Text] [Related]
19. Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome.
Arnaud P; Hanna N; Aubart M; Leheup B; Dupuis-Girod S; Naudion S; Lacombe D; Milleron O; Odent S; Faivre L; Bal L; Edouard T; Collod-Beroud G; Langeois M; Spentchian M; Gouya L; Jondeau G; Boileau C
J Med Genet; 2017 Feb; 54(2):100-103. PubMed ID: 27582083
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the FBN1 gene in a cohort of patients with Marfan Syndrome: A 10-year single center experience.
Mannucci L; Luciano S; Salehi LB; Gigante L; Conte C; Longo G; Ferradini V; Piumelli N; Brancati F; Ruvolo G; Novelli G; Sangiuolo F
Clin Chim Acta; 2020 Feb; 501():154-164. PubMed ID: 31730815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
